We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsLeafly PicksCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Leafly Picks
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
  • Help
  1. Home
  2. News
  3. Politics
  4. Peru Approves Medical Cannabis Legalization Bill
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Politics

Peru Approves Medical Cannabis Legalization Bill

Lisa RoughLast updated July 28, 2020

After intense debate, the Peruvian Congress voted to legalize cannabis for medical use. The bill must be approved by President Pedro Pablo Kuczynski before it becomes law.

Legislative Bill 1393, which passed on a 67–5 vote with three members abstaining—was proposed by lawmaker Alberto de Belaunde. The measure would allow the cultivation and storage of medicinal cannabis products with oversight by a regulatory committee made up of the Ministries of Agriculture and Health, the National Commission for Development and Life Without Drugs (DEVIDA), as well as an appointed panel of cannabis experts.

The bill was introduced over the summer along with two other bills to legalize cannabis for medicinal use. It was pitched as a solution for suffering patients after law enforcement raided a community cannabis cultivation site last February. Ana Alvarez, a cannabis advocate and founder of the association Buscando Esperanza, had been illegally producing cannabis oil to treat her son Anthony, who suffers from severe seizure disorder Lennox-Gastaut syndrome, when the family’s home was raided.

Alvarez criticized another bill introduced by the executive branch that would have allowed the importation and sales of medical cannabis products, pointing out that it would be costly and inefficient to import expensive products from abroad, rather than allowing cultivation within Peru’s borders.

“Mothers are happy because it is already a step forward in this long journey. We expect self-cultivation to be allowed,” Alvarez said in support of the bill. “The import offers very high prices that would affect low-income families.”

After being approved by the Health Committee on Oct. 11, Committee President and Congressman Eloy Narváez spoke out in favor of the measure. Defense Commission President Javier Velásquez Quesquén supported the measure in September, indicating that the cultivation and production must first be authorized by the executive branch through such institutions as authorized laboratories and the National Institute of Health.

The law will allow residents with certain qualifying conditions, such as Parkinson’s disease, cancer, and epilepsy, to use cannabis and its derivatives as part of a course of treatment. Belaunde said that regulations for the production of medicinal cannabis oil will be drafted within the next 60 days if approved by President Kuczynsnki.

Kuczynski has been generally supportive of cannabis in the past, saying “Si quieren fumar su troncho no es el fin del mondo,” or “If they want to smoke [in moderate doses], it’s not the end of the world.”

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
lawslegalizationmedical marijuanaPeru
Lisa Rough
Lisa Rough
Lisa is a former associate editor at Leafly, where she specialized in legislative cannabis policy and industry topics.
View Lisa Rough's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.